Unison Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
LMFP
HGIM
DC
CF
MIHAS
Unison Advisors's ELV Position: Q2 2026 in Review
Unison Advisors increased its Elevance Health (ELV) stake by 0.47% in Q2 2026, buying an estimated $13K and bringing the position to 7,465 shares worth $2.89M. The position accounts for 0.2% of the portfolio, ranked #59.
Unison Advisors first reported a position in ELV in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.18M in Q1 2025. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Unison Advisors held 7,465 shares of Elevance Health worth $2.89M as of Q2 2026.
- Unison Advisors bought 35 Elevance Health shares in Q2 2026, an estimated $13K.
- Elevance Health made up 0.2% of Unison Advisors's portfolio in Q2 2026, its #59 holding.
- Unison Advisors first reported a position in Elevance Health in Q1 2025 and has held it in 6 quarters since.
- Unison Advisors's Elevance Health position peaked at $3.18M in Q1 2025.
- 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Unison Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.